Aether Industries (AETHER) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
30 Jun, 2026Executive summary
FY26 revenue grew 38% year-over-year to ₹11,601 million, with EBITDA up 53% to ₹3,547 million and PAT up 39% to ₹2,195 million, driven by strong pricing, new product launches, and robust CEM/CRAMS business models.
19 new marquee clients were added and over 50 customer/certification audits completed, reflecting operational excellence.
Major R&D expansion underway, including new labs, fume hoods, and a new facility to double capacity.
Appointment of a new business development leader for Europe to drive international growth.
Strategic focus on innovation, customer integration, and execution to maintain competitive advantage.
Financial highlights
FY26 consolidated revenue: ₹11,601 million (up 38% YoY); EBITDA: ₹3,547 million (up 53% YoY); PAT: ₹2,195 million (up 39% YoY).
Q4 FY26 revenue: ₹3,051 million, EBITDA: ₹814 million, PAT: ₹540 million; Q4 impacted by a ₹70 million inventory loss from a warehouse fire.
Working capital cycle reduced to 179 days from 194 days YoY; cash flow from operations increased to ₹1,424 million.
CapEx for FY26 was ₹3,838 million; FY27 CapEx expected at ₹3,000–3,500 million, mainly for Site 5 and new R&D site.
Cash and cash equivalents at FY26 end stood at ₹57 million.
Outlook and guidance
Pricing environment expected to remain strong for the next two to three quarters, with sustained demand and margin stability.
Commercialization of Site 5 and ramp-up of Site 3+ and Site 4 to drive revenue growth in FY27.
Targeting 70% of revenue from CRAMS and CM by FY30, with ongoing shift in product mix.
Working capital days expected to decline to 160–150 by end of FY27.
EBITDA margin guidance for FY27: 29–30%; PAT margin: 19–20%.
Latest events from Aether Industries
- Q1 FY27 delivered 27% revenue growth, margin expansion, and major R&D and insurance milestones.AETHER
Q1 26/2731 Jul 2026 - Q3 FY26 revenue up 44% YoY, EBITDA up 75%, with strong growth and capacity expansions.AETHER
Q3 25/269 Jul 2026 - Q4 FY25 revenue up 90% Y/Y, PAT up 3621% Y/Y, with strong expansion and risk management.AETHER
Q4 24/259 Jul 2026 - Q3 FY25 delivered strong revenue and profit growth, supported by expansion and new contracts.AETHER
Q3 24/258 Jul 2026 - Q1 FY26 revenue up 35% Y/Y, EBITDA up 94%, with major expansions and Milliken contract signed.AETHER
Q1 25/268 Jul 2026 - Q1 FY25 delivered strong growth, margin recovery, and major capital raise approval.AETHER
Q1 24/252 Feb 2026 - Q2 and H1 FY25 delivered strong growth, robust margins, and ongoing expansion initiatives.AETHER
Q2 24/2519 Dec 2025 - Q2 FY26 delivered 38% revenue and 70% EBITDA growth, with CEM/CRAMS over 50% of sales.AETHER
Q2 25/2619 Dec 2025